About Us


Doloromics's core mission is to eradicate pain in patients who remain tragically underserved by current standards of care


To make curing chronic pain a reality we have completely focused our energy on quickly adopting cutting-edge technologies to build our platform- DOLOReS - and move rapidly towards therapeutic development. All our discovery work occurs in human tissues and using this data, we’ve built a start-to-finish platform that can identify and validate novel therapeutic targets. We’re currently performing drug discovery in-house and are open to strategic partnerships for getting effective therapies to patients as quickly as possible.

Interested in partnering or want to know more? Contact us and we’ll follow-up.